I placed a topic for discussion last night on a Texas biotech set to release an announcement on CD19

By backoffice, June 16, 2017

on June 23rd that look promising for big returns (according to the offer). I did some investigating and came up with $BLCM,
Bellicum Pharmaceuticals that also has an orphan drug in development. Maybe the Doc can give use some inside on this.

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

Share your thoughts...

Be the First to Comment!